Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions

Critical Reviews in Microbiology

Volumn 41, Issue 2, 2015, Pages 238-260

  Rusnati, Marco ^a   Chiodelli, Paola ^a   Bugatti, Antonella ^a   Urbinati, Chiara ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Protein protein interactions; Virus binding assays; Virus receptors

Indexed keywords

ANTIVIRUS AGENT; CELL SURFACE RECEPTOR; VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; PROTEIN BINDING;

BIOLOGY; EXPERIMENTATION; HEPATITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MEASLES VIRUS; POXVIRIDAE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SARS CORONAVIRUS; SURFACE PLASMON RESONANCE; VACCINIA VIRUS; VIRION; VIROLOGY; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS LIKE AGENT; WART VIRUS; DRUG EFFECTS; HOST PATHOGEN INTERACTION; PROCEDURES; VIRAL PHENOMENA AND FUNCTIONS; VIRUS;

EUKARYOTA;

HOST-PATHOGEN INTERACTIONS; PROTEIN BINDING; SURFACE PLASMON RESONANCE; VIROLOGY; VIRUS ATTACHMENT; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUSES;

EID: 84929728689     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2013.826177     Document Type: Review

References (276)

1. Ahmad M, Raut S, Pyaram K, et al. (2010). Domain swapping reveals complement control protein modules critical for imparting cofactor and Decay-Accelerating activities in vaccinia virus complement control protein. J Immunol 185:6128-37
2. Alba R, Bradshaw AC, Parker AL, et al. (2009). IDentification of coagulation factor (F)X binding sites on the aDenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114:965-71
3. Alejo A, Ruiz-Arguello MB, Ho Y, et al. (2006). A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A 103:5995-6000
4. Anraku K, Fukuda R, Takamune N, et al. (2010). Highly sensitive analysis of the interaction between HIV-1 Gag and phosphoinositiDe Derivatives based on surface plasmon resonance. Biochemistry 49: 5109-16
5. Aoki Y, Narazaki M, Kishimoto T, Tosato G. (2001). Receptor engagement by viral interleukin-6 encoDed by Kaposi sarcomaassociated herpesvirus. Blood 98:3042-9
6. Bahar MW, Kenyon JC, Putz MM, et al. (2008). Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog 4:e5
7. Balasubramanian N, Bai P, Buchek G, et al. (2010). Physical interaction between the herpes simplex virus type 1 exonuclease, UL12, and the DNA double-strand break-sensing MRN complex. J Virol 84: 12504-14
8. Bamdad C. (1998) the use of variable Density self-Assembled monolayers to probe the structure of a target molecule. Biophys J 75: 1989-96
9. Baritaki S, Zafiropoulos A, Sioumpara M, et al. (2002). Ionic interaction of the HIV-1 V3 domain with CCR5 and Deregulation of T lymphocyte function. Biochem Biophys Res Commun 298:574-80
10. Barth H, Schafer C, Adah MI, et al. (2003). Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278:41003-12
11. Barth H, Schnober EK, Zhang F, et al. (2006). Viral and cellular Determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 80:10579-90
12. Barton ES, Connolly JL, Forrest JC, et al. (2001). Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem 276:2200-11
13. Beck CG, StuDer C, Zuber JF, et al. (2001) the viral CC chemokinebinding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site. J Biol Chem 276: 43270-6
14. BeerheiDe W, Bernard HU, Tan YJ, et al. (1999). Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J Natl Cancer Inst 91:1211-20
15. Bernet J, Mullick J, Panse Y, et al. (2004). Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J Virol 78:9446-57
16. Bieniasz PD. (2009) the cell biology of HIV-1 virion genesis. Cell Host Microbe 5:550-8
17. Biorn AC, Cocklin S, Madani N, et al. (2004). MoDe of action for linear peptiDe inhibitors of HIV-1 gp120 interactions. Biochemistry 43: 1928-38
18. Birkmann A, Mahr K, Ensser A, et al. (2001). Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 75:11583-93
19. Bobardt MD, Saphire AC, Hung HC, et al. (2003). SynDecan captures, protects, and transmits HIV to T lymphocytes. Immunity 18:27-39
20. Boivin S, Hart DJ. (2011). Interaction of the influenza A virus polymerase PB2 C-terminal region with importin {alpha} isoforms proviDes insights into host adaptation and polymerase assembly. J Biol Chem 286:10439-48
21. Boulter JM, Schmitz N, Sewell AK, et al. (2007). Potent T cell agonism mediated by a very rapid TCR/pMHC interaction. Eur J Immunol 37: 798-806
22. Bourhis JM, Receveur-Brechot V, Oglesbee M, et al. (2005) the intrinsically disorDered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolDed. Protein Sci 14:1975-92
23. BowDen TA, Yvonne Jones E, Stuart DI. (2011). Cells unDer siege: viral glycoprotein interactions at the cell surface. J Struct Biol 175:120-6
24. Brown JR, Magid-Slav M, Sanseau P, Rajpal DK. (2011). Computational biology approaches for selecting host-pathogen drug targets. Drug Discov Today 16:229-36
25. Bugatti A, ChioDelli P, Rosenbluh J, et al. (2010). BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the Development of multitarget inhibitors of extracellular Tat. Antiviral Res 87:30-9
26. Bugatti A, Giagulli C, Urbinati C, et al. (2013). Molecular interaction studies of HIV-1 matrix protein p17 and heparin: iDentification of the heparin-binding motif of p17 as a target for the Development of multitarget antagonists. J Biol Chem 288:1150-61
27. Bugatti A, Urbinati C, Ravelli C, et al. (2007). Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunoDeficiency virus type 1 Tat and gp120 proteins. Antimicrob Agents Chemother 51:2337-45
28. Caccuri F, Giagulli C, Bugatti A, et al. (2012). HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2, Proc Natl Acad Sci U S A 109: 14580-5
29. CalDerara S, Xiang Y, Moss B. (2001). Orthopoxvirus IL-18 binding proteins: affinities and antagonist activities. Virology 279:22-6
30. Casasnovas JM, Springer TA. (1995). Kinetics and thermodynamics of virus binding to receptor. Studies with rhinovirus, intercellular adhesion molecule-1 (ICAM-1), and surface plasmon resonance. J Biol Chem 270:13216-24
31. Chaloin O, Peter JC, Briand JP, et al. (2005) the N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction. Cell Mol Life Sci 62:355-61
32. Chaudhari A, Fialho AM, Ratner D, et al. (2006). Azurin, Plasmodium falciparum malaria and HIV/AIDS: inhibition of parasitic and viral growth by Azurin. Cell Cycle 5:1642-8
33. Chen H, Gill A, Dove BK, et al. (2005a). Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance. J Virol 79:1164-79
34. Chen L, Gui C, Luo X, et al. (2005b). Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 79:7095-103
35. Chen Y, Bai P, Mackay S, et al. (2012). Herpes simplex virus type 1 helicase-primase: DNA binding and consequent protein oligomerization and primase activation. J Virol 85:968-78
36. Chen Z, Mi L, Xu J, et al. (2005c). Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis 191:755-60
37. Cheng AC, Coleman RG, Smyth KT, et al. (2007). Structure-based maximal affinity moDel predicts small-molecule druggability. Nat Biotechnol 25:71-5
38. Chesnokova LS, Hutt-Fletcher LM. (2011). Fusion of Epstein-Barr virus with epithelial cells can be triggered by alphavbeta5 in addition to alphavbeta6 and alphavbeta8, and integrin binding triggers a conformational change in glycoproteins gHgL. J Virol 85:13214-23
39. Chien MP, Jiang S, Chang DK. (2008) the function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope proteinmediated cell fusion. FASEB J 22:1179-92
40. Chinami M, Inoue M, Masunaga K, et al. (1996). Nucleic acid binding by zinc finger-like motif of human papillomavirus type 16 E7 oncoprotein. J Virol Methods 59:173-6
41. ChioDelli P, Urbinati C, Mitola S, et al. (2012). Sialic acid associated with alphavbeta3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation. J Biol Chem 287:20456-66
42. Chiorini JA, Zimmermann B, Yang L, et al. (1998). Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-DepenDent protein kinase PKA by the regulatory proteins of aDeno-Associated virus type 2. Mol Cell Biol 18:5921-9
43. Choi AG, Wong J, Marchant D, Luo H. (2012) the ubiquitinproteasome system in positive-strand RNA virus infection. Rev Med Virol 23:85-96
44. Choi KJ, Lim CW, Yoon MY, et al. (2004). Quantitative analysis of the interaction between the envelope protein domains and the core protein of human hepatitis B virus. Biochem Biophys Res Commun 319: 959-66
45. Cocklin S, Gopi H, Querido B, et al. (2007). Broad-spectrum anti-human immunoDeficiency virus (HIV) potential of a peptiDe HIV type 1 entry inhibitor. J Virol 81:3645-8
46. Corjon S, Gonzalez G, Henning P, et al. (2011). Cell entry and trafficking of human aDenovirus bound to blood factor X is Determined by the fiber serotype and not hexon:heparan sulfate interaction. PLoS One 6:e18205
47. Critchley P, Dimmock NJ. (2004). Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance. Bioorg Med Chem 12:2773-80
48. Crublet E, Andrieu JP, Vives RR, Lortat-Jacob H. (2008) the HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site. J Biol Chem 283: 15193-200
49. Cupelli K, Muller S, Persson BD, et al. (2010). Structure of aDenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B aDenoviruses. J Virol 84: 3189-200
50. Dekker J, Kanellopoulos PN, Van Oosterhout JA, et al. (1998). ATPinDepenDent DNA unwinding by the aDenovirus single-stranDed DNA binding protein requires a flexible DNA binding loop. J Mol Biol 277: 825-38
51. Dey AK, Khati M, Tang M, et al. (2005). An aptamer that neutralizes R5 strains of human immunoDeficiency virus type 1 blocks gp120-CCR5 interaction. J Virol 79:13806-10
52. Dey B, Svehla K, Xu L, et al. (2009). Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced coreceptor binding site. PLoS Pathog 5:e1000445
53. Dignam SS, Collaco RF, Bieszczad J, et al. (2007). Coupled ATP and DNA binding of aDeno-Associated virus Rep40 helicase. Biochemistry 46:568-76
54. Dimmock NJ, Hardy SA. (2004). Valency of antibody binding to virions and its Determination by surface plasmon resonance. Rev Med Virol 14:123-35
55. Ely LK, Beddoe T, Clements CS, et al. (2006). Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction. Proc Natl Acad Sci U S A 103:6641-6
56. Engelhardt OG, Fodor E. (2006). Functional association between viral and cellular transcription during influenza virus infection. Rev Med Virol 16:329-45
57. Esteban DJ, Buller RM. (2004). IDentification of residues in an orthopoxvirus interleukin-18 binding protein involved in ligand binding and species specificity. Virology 323:197-207
58. Esteban DJ, Nuara AA, Buller RM. (2004). Interleukin-18 and glycosaminoglycan binding by a protein encoDed by Variola virus. J Gen Virol 85:1291-9
59. Falkenberg M, Bushnell DA, Elias P, Lehman IR. (1997) the UL8 subunit of the heterotrimeric herpes simplex virus type 1 helicaseprimase is required for the unwinding of single strand DNAbinding protein (ICP8)-coated DNA substrates. J Biol Chem 272: 22766-70
60. Feng Y, McKee K, Tran K, et al. (2011). Biochemically Defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site. J Biol Chem 287:5673-86
61. FernanDez De Marco MDel M, Alejo A, Hudson P, et al. (2009) the highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. FASEB J 24:1479-88
62. Ferreira ME, Hermann S, Prochasson P, et al. (2005). Mechanism of transcription factor recruitment by acidic activators. J Biol Chem 280: 21779-84
63. Ferrer M, SulliVan BJ, Godbout KL, et al. (1999). Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120. J Pept Res 54:32-42
64. Fiorentini S, Marini E, Caracciolo S, Caruso A. (2006). Functions of the HIV-1 matrix protein p17. New Microbiol 29:1-10
65. Flamminio G, Caruso A, Poiesi C, et al. (1995). Aspects of molecular interaction between HIV p17 and human gamma interferon. AIDS Res Hum Retroviruses 11:1441-7
66. Fournane S, Charbonnier S, Chapelle A, et al. (2010). Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1. J Mol Recognit 24:511-23
67. Frey G, Peng H, Rits-Volloch S, et al. (2008). A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies. Proc Natl Acad Sci U S A 105:3739-44
68. Fu J, Li L, Bouvier M. (2011). ADenovirus E3-19K proteins of different serotypes and subgroups have similar, yet distinct, immunomodulatory functions toward major histocompatibility class I molecules. J Biol Chem 286:17631-9
69. Gakamsky DM, Lewitzki E, Grell E, et al. (2007). Kinetic eviDence for a ligand-binding-induced conformational transition in the T cell receptor. Proc Natl Acad Sci U S A 104:16639-44
70. Galdiero S, Falanga A, Vitiello G, et al. (2010). Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process. Biochim Biophys Acta 1798:579-91
71. Galinier R, Gout E, Lortat-Jacob H, et al. (2002). ADenovirus protein involved in virus internalization recruits ubiquitin-protein ligases. Biochemistry 41:14299-305
72. Gallay P. (2004). SynDecans and HIV-1 pathogenesis. Microbes Infect 6: 617-22
73. Gallego J, Greatorex J, Zhang H, et al. (2003). Rev binds specifically to a purine loop in the SL1 region of the HIV-1 leaDer RNA. J Biol Chem 278:40385-91
74. Gallo M, Bottomley MJ, Pennestri M, et al. (2010). Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: the basis of the genotype 1b vs. 3a inhibitor potency shift. Virology 405:424-38
75. Gallo SA, Wang W, Rawat SS, et al. (2006) theta-Defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem 281:18787-92
76. Garrus JE, von Schwedler UK, Pornillos OW, et al. (2001). Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65
77. Gershon PD, Khilko S. (1995). Stable chelating linkage for reversible immobilization of oligohistidine tagged proteins in the BIAcore surface plasmon resonance Detector. J Immunol Methods 183: 65-76
78. Ghanam RH, Samal AB, FernanDez TF, Saad JS. (2012). Role of the HIV-1 matrix protein in Gag intracellular trafficking and targeting to the plasma membrane for virus assembly. Front Microbiol 3:55
79. Giagulli C, Magiera AK, Bugatti A, et al. (2012). HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation. Blood 119: 2274-83
80. Gorshkova, II, Rausch JW, Le Grice SF, Crouch RJ. (2001). HIV-1 reverse transcriptase interaction with moDel RNA-DNA duplexes. Anal Biochem 291:198-206
81. Gras S, Burrows SR, Kjer-Nielsen L, et al. (2009) the shaping of T cell receptor recognition by self-tolerance. Immunity 30:193-203
82. Gras S, Chen Z, Miles JJ, et al. (2010). Allelic polymorphism in the T cell receptor and its impact on immune responses. J Exp Med 207: 1555-67
83. Greco-Stewart V, Pelchat M. (2010). Interaction of host cellular proteins with components of the hepatitis Delta virus. Viruses 2:189-212
84. Greig JA, Buckley SM, Waddington SN, et al. (2009). Influence of coagulation factor x on in vitro and in vivo gene Delivery by aDenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Mol Ther 17:1683-91
85. Guglielmi KM, Kirchner E, Holm GH, et al. (2007). Reovirus binding Determinants in junctional adhesion molecule-A. J Biol Chem 282: 17930-40
86. Hamilton MD, Nuara AA, Gammon DB, et al. (2007). Duplex strand joining reactions catalyzed by vaccinia virus DNA polymerase. Nucleic Acids Res 35:143-51
87. He N, Liu M, Hsu J, et al. (2010). HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol Cell 38:428-38
88. Herschhorn A, Oz-Gleenberg I, Hizi A. (2008a). Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamiDe. Biochemistry 47:490-502
89. Herschhorn A, Oz-Gleenberg I, Hizi A. (2008b). Quantitative analysis of the interactions between HIV-1 integrase and retroviral reverse transcriptases. Biochem J 412: 163-70
90. Hidari KI, Shimada S, Suzuki Y, Suzuki T. (2007). Binding kinetics of influenza viruses to sialic acid-containing carbohydrates. Glycoconj J 24:583-90
91. Hijazi K, Wang Y, Scala C, et al. (2011). DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4. PLoS One 6: e28307
92. Hilgendorf A, Lindberg J, Ruzsics Z, et al. (2003). Two distinct transport motifs in the aDenovirus E3/10.4-14.5 proteins act in concert to downmodulate apoptosis receptors and the epiDermal growth factor receptor. J Biol Chem 278:51872-84
93. Ho Y, Hsiao JC, Yang MH, et al. (2005) the oligomeric structure of vaccinia viral envelope protein A27L is essential for binding to heparin and heparan sulfates on cell surfaces: a structural and functional approach using site-specific mutagenesis. J Mol Biol 349:1060-71
94. Hsieh MJ, White PJ, Pouton CW. (2010). Interaction of viruses with host cell molecular motors. Curr Opin Biotechnol 21:633-9
95. Huang CY, Hsu YL, Chiang WL, Hou MH. (2009). Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein. Protein Sci 18:2209-18
96. Hyser JM, Zeng CQ, Beharry Z, et al. (2008). Epitope mapping and use of epitope-specific antisera to characterize the VP5 binding site in rotavirus SA11 NSP4. Virology 373:211-28
97. Jacotot E, Ferri KF, El Hamel C, et al. (2001). Control of mitochondrial membrane permeabilization by aDenine nucleotiDe translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med 193: 509-19
98. Jennings TA, Chen Y, Sikora D, et al. (2008). RNA unwinding activity of the hepatitis C virus NS3 helicase is modulated by the NS5B polymerase. Biochemistry 47:1126-35
99. Jenwitheesuk E, Horst JA, Rivas KL, et al. (2008). Novel paradigms for drug discovery: computational multitarget screening. Trends Pharmacol Sci 29:62-71
100. Jo BB, Jeong MS, Park SY, et al. (2011) the binding of hepatitis B virus X protein to glioma-Associated oncogene homologue 1 and its biological characterization in vitro. Appl Biochem Biotechnol 165: 109-22
101. Johnson TR, McLellan JS, Graham BS. (2011). Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2. J Virol 86:1339-47
102. Jung SO, Ro HS, Kho BH, et al. (2005). Surface plasmon resonance imaging-based protein arrays for high-throughput screening of protein-protein interaction inhibitors. Proteomics 5:4427-31
103. Kadaveru K, Vyas J, Schiller MR. (2008). Viral infection and human disease-insights from minimotifs. Front Biosci 13:6455-71
104. Kang H, Yu J, Jung G. (2008). Phosphorylation of hepatitis B virus core C-terminally truncated protein (Cp149) by PKC increases capsid assembly and stability. Biochem J 416:47-54
105. Kashuba E, Yurchenko M, Yenamandra SP, et al. (2010). Epstein-Barr virus-encoDed EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53. Int J Cancer 128:817-25
106. Kastritis PL, Bonvin AM. (2010). Are scoring functions in proteinprotein docking ready to predict interactomes? Clues from a novel binding affinity benchmark. J Proteome Res 9:2216-25
107. Kaufmann B, Baxa U, Chipman PR, et al. (2005). Parvovirus B19 does not bind to membrane-Associated globosiDe in vitro. Virology 332: 189-98
108. Khilko SN, Corr M, Boyd LF, et al. (1993). Direct Detection of major histocompatibility complex class I binding to antigenic peptiDes using surface plasmon resonance. PeptiDe immobilization and characterization of binding specificity. J Biol Chem 268: 15425-34
109. Khurana S, Chearwae W, Castellino F, et al. (2010). Vaccines with MF59 adjuVant expand the antibody repertoire to target protective sites of panDemic avian H5N1 influenza virus. Sci Transl Med 2: 15ra5
110. Kim M, Qiao Z, Yu J, et al. (2007). Immunogenicity of recombinant human immunoDeficiency virus type 1-like particles expressing gp41 Derivatives in a pre-fusion state. Vaccine 25:5102-14
111. Kim MY, Jeong S. (2003). RNA aptamers that bind the nucleocapsid protein contain pseudoknots. Mol Cells 16:413-17
112. Kim SJ, Kim MY, Lee JH, et al. (2002). Selection and stabilization of the RNA aptamers against the human immunoDeficiency virus type-1 nucleocapsid protein. Biochem Biophys Res Commun 291: 925-31
113. Kirby I, Davison E, Beavil AJ, et al. (2000). IDentification of contact residues and Definition of the CAR-binding site of aDenovirus type 5 fiber protein. J Virol 74:2804-13
114. Kirby I, Lord R, Davison E, et al. (2001). ADenovirus type 9 fiber knob binds to the coxsackie B virus-ADenovirus receptor (CAR) with lower affinity than fiber knobs of other CAR-binding aDenovirus serotypes. J Virol 75:7210-14
115. Krishnan L, Matreyek KA, Oztop I, et al. (2010) the requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunoDeficiency virus type 1 capsid and not integrase. J Virol 84:397-406
116. Lam SN, Acharya P, Wyatt R, et al. (2008). Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry. Bioorg Med Chem 16:10113-20
117. Lateef Z, Baird MA, Wise LM, et al. (2009). Orf virus-encoDed chemokine-binding protein is a potent inhibitor of inflammatory monocyte recruitment in a mouse skin moDel. J Gen Virol 90:1477-82
118. Lea SM, Powell RM, McKee T, et al. (1998). Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55. J Biol Chem 273: 30443-7
119. Leavitt SA, Schon A, Klein JC, et al. (2004). Interactions of HIV-1 proteins gp120 and Nef with cellular partners Define a novel allosteric paradigm. Curr Protein Pept Sci 5:1-8
120. Lee SJ, Shim HY, Hsieh A, et al. (2009). Hepatitis B virus core interacts with the host cell nucleolar protein, nucleophosmin 1. J Microbiol 47: 746-52
121. Lehrer RI, Jung G, Ruchala P, et al. (2009). Multivalent binding of carbohydrates by the human alpha-Defensin, HD5. J Immunol 183: 480-90
122. Lembo D, Donalisio M, Rusnati M, et al. (2008). Sulfated K5 Escherichia coli polysacchariDe Derivatives as wiDe-range inhibitors of genital types of human papillomavirus. Antimicrob Agents Chemother 52:1374-81
123. Lewallen DM, Siler D, Iyer SS. (2009). Factors affecting protein-glycan specificity: effect of spacers and incubation time. Chembiochem 10: 1486-9
124. Lim CS, Seet BT, Ingham RJ, et al. (2007) the K15 protein of Kaposis sarcoma-Associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective SH3 domain interaction. Biochemistry 46:9874-85
125. Lin S, Long S, Ramirez SM, et al. (2000). Characterization of the helix clamp motif of HIV-1 reverse transcriptase using MALDI-TOF MS and surface plasmon resonance. Anal Chem 72:2635-40
126. Lindahl U, Lidholt K, Spillmann D, Kjellen L. (1994). More to heparin than anticoagulation. Thromb Res 75:1-32
127. Lippe R. (2012). Deciphering novel host-herpesvirus interactions by virion proteomics. Front Microbiol 3:181
128. Liu H, Fu J, Bouvier M. (2007). Allele-And locus-specific recognition of class I MHC molecules by the immunomodulatory E3-19K protein from aDenovirus. J Immunol 178:4567-75
129. Liu J, Deng Y, Dey AK, et al. (2009a). Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation. Biochemistry 48:2915-23
130. Liu Y, Cherry JJ, Dineen JV, et al. (2009b). Determinants of stability for the E6 protein of papillomavirus type 16. J Mol Biol 386:1123-37
131. Lord R, Parsons M, Kirby I, et al. (2006). Analysis of the interaction between RGD-expressing aDenovirus type 5 fiber knob domains and alphavbeta3 integrin reveals distinct binding profiles and intracellular trafficking. J Gen Virol 87:2497-505
132. Lortat-Jacob H, Chouin E, Cusack S, Van Raaij MJ. (2001). Kinetic analysis of aDenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions. J Biol Chem 276: 9009-15
133. Luo C, Luo H, Zheng S, et al. (2004a). Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun 321:557-65
134. Luo H, Chen Q, Chen J, et al. (2005) the nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. FEBS Lett 579:2623-8
135. Luo H, Wu D, Shen C, et al. (2006). Severe acute respiratory syndrome coronavirus membrane protein interacts with nucleocapsid protein mostly through their carboxyl termini by electrostatic attraction. Int J Biochem Cell Biol 38:589-99
136. Luo H, Ye F, Sun T, et al. (2004b). In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS. Biophys Chem 112:15-25
137. Maillard P, Lavergne JP, Siberil S, et al. (2004). Fcgamma receptor-like activity of hepatitis C virus core protein. J Biol Chem 279:2430-7
138. Majka J, Speck C. (2007). Analysis of protein-DNA interactions using surface plasmon resonance. Adv Biochem Eng Biotechnol 104:13-36
139. Majumdar A, Bhattacharya R, Basak S, et al. (2004). P-protein of Chandipura virus is an N-protein-specific chaperone that acts at the nucleation stage. Biochemistry 43:2863-70
140. Mamikonyan G, Kiyatkin A, Movsesyan N, et al. (2008). Detection of the active components of calf thymus nuclear proteins (TNP), histones that are binding with high affinity to HIV-1 envelope proteins and CD4 molecules. Curr HIV Res 6:318-26
141. ManDenius CF, Wang R, AlDen A, et al. (2008). Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance. Anal Chim Acta 623:66-75
142. Manninen A, Hiipakka M, Vihinen M, et al. (1998). SH3-Domain binding function of HIV-1 Nef is required for association with a PAKrelated kinase. Virology 250:273-82
143. Mark L, Lee WH, Spiller OB, et al. (2004) the Kaposis sarcomaassociated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system. J Biol Chem 279:45093-101
144. Marks RM, Lu H, Sundaresan R, et al. (2001). Probing the interaction of Dengue virus envelope protein with heparin: assessment of glycosaminoglycan-Derived inhibitors. J Med Chem 44:2178-87
145. Martin-Garcia J, Cocklin S, Chaiken IM, Gonzalez-Scarano F. (2005). Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-Adapted human immunoDeficiency virus type 1 isolate. J Virol 79:6703-13
146. Matsubara M, Jing T, Kawamura K, et al. (2005). Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. Protein Sci 14:494-503
147. McDermott Jr BM, Rux AH, Eisenberg RJ, et al. (2000). Two distinct binding affinities of poliovirus for its cellular receptor. J Biol Chem 275:23089-96
148. Meng B, Marriott AC, Dimmock NJ. (2010) the receptor preference of influenza viruses. Influenza Other Respi Viruses 4:147-53
149. Meng X, Leman M, Xiang Y. (2007). Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 358:211-20
150. Miles JJ, Bulek AM, Cole DK, et al. (2010). Genetic and structural basis for selection of a ubiquitous T cell receptor Deployed in Epstein-Barr virus infection. PLoS Pathog 6:e1001198
151. Montanuy I, Alejo A, Alcami A. (2011). Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses. FASEB J 26: 1960-71
152. Moriishi K, Matsuura Y. (2012). Exploitation of lipid components by viral and host proteins for hepatitis C virus infection. Front Microbiol 3:54
153. Moulard M, Lortat-Jacob H, Mondor I, et al. (2000). Selective interactions of polyanions with basic surfaces on human immunoDeficiency virus type 1 gp120. J Virol 74:1948-60
154. Muller S, Zocher G, Steinle A, Stehle T. (2010). Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands. PLoS Pathog 6:e1000723
155. Munshi UM, Kim J, Nagashima K, et al. (2007). An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J Biol Chem 282:3847-55
156. Myszka DG, Sweet RW, Hensley P, et al. (2000). Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A 97:9026-31
157. Nakajima H, Cocquerel L, Kiyokawa N, et al. (2005). Kinetics of HCV envelope proteins interaction with CD81 large extracellular loop. Biochem Biophys Res Commun 328:1091-100
158. Navaratnarajah CK, Vongpunsawad S, Oezguen N, et al. (2008). Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150). J Biol Chem 283:11763-71
159. Navratilova I, Macdonald G, Robinson C, et al. (2012). Biosensor-based approach to the iDentification of protein kinase ligands with dual-site moDes of action. J Biomol Screen 17:183-93
160. Navratilova I, Papalia GA, Rich RL, et al. (2007) thermodynamic benchmark study using Biacore technology. Anal Biochem 364: 67-77
161. Navratilova I, Sodroski J, Myszka DG. (2005). Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Anal Biochem 339:271-81
162. Nedialkov YA, Shooltz DD, Triezenberg SJ. (2003). Purification and protein interaction assays of the VP16C transcription activation domain. Methods Enzymol 370:522-35
163. Nedialkov YA, Triezenberg SJ. (2004). Quantitative assessment of in vitro interactions implicates TATA-binding protein as a target of the VP16C transcriptional activation region. Arch Biochem Biophys 425: 77-86
164. Negrete OA, Wolf MC, Aguilar HC, et al. (2006). Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2:e7
165. Neveu G, Cassonnet P, Vidalain PO, et al. (2012). Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase. Methods 58:349-59
166. Ng A, Tscharke DC, Reading PC, Smith GL. (2001) the vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. J Gen Virol 82:2095-105
167. Ng AK, Chan WH, Choi ST, et al. (2012). Influenza polymerase activity correlates with the strength of interaction between nucleoprotein and PB2 through the host-specific residue K/E627. PLoS One 7: e36415
168. Ng AK, Zhang H, Tan K, et al. (2008). Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine Design. FASEB J 22:3638-47
169. Nilsson EC, Storm RJ, Bauer J, et al. (2010) the GD1a glycan is a cellular receptor for aDenoviruses causing epiDemic keratoconjunctivitis. Nat Med 17:105-9
170. Nonaka M, Ma BY, Ohtani M, et al. (2007). Subcellular localization and physiological significance of intracellular mannan-binding protein. J Biol Chem 282:17908-20
171. Nowak SA, Chou T. (2009). Mechanisms of receptor/coreceptormediated entry of enveloped viruses. Biophys J 96:2624-36
172. Nyanguile O, Devogelaere B, Vijgen L, et al. (2010). 1a/1b subtype profiling of nonnucleosiDe polymerase inhibitors of hepatitis C virus. J Virol 84:2923-34
173. Oda M, Nakamura H. (2000) thermodynamic and kinetic analyses for unDerstanding sequence-specific DNA recognition. Genes Cells 5: 319-26
174. Oda S, Franklin E, Khan AR. (2011). Poxvirus A46 protein binds to TIR domain-containing Mal/TIRAP via an alpha-helical sub-domain. Mol Immunol 48:2144-50
175. Okamoto T, Omori H, Kaname Y, et al. (2008). A single-Amino-Acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J Virol 82:3480-9
176. Okumoto Y, Ohmichi T, Sugimoto N. (2002). Immobilized small Deoxyribozyme to distinguish RNA secondary structures. Biochemistry 41:2769-73
177. Ou HD, May AP, OShea CC. (2010) the critical protein interactions and structures that elicit growth Deregulation in cancer and viral replication. Wiley Interdiscip Rev Syst Biol Med 3:48-73
178. Owen SM, Rudolph DL, Wang W, et al. (2004). RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses 20:1157-65
179. Paal K, Baeuerle PA, Schmitz ML. (1997). Basal transcription factors TBP and TFIIB and the viral coactivator E1A 13S bind with distinct affinities and kinetics to the transactivation domain of NF-kappaB p65. Nucleic Acids Res 25:1050-5
180. Pan YS, Wei HJ, Chang CC, et al. (2010). Construction and characterization of insect cell-Derived influenza VLP: cell binding, fusion, and EGFP incorporation. J Biomed Biotechnol 2010:506363
181. Panayotou G, Brown T, Barlow T, et al. (1998). Direct measurement of the substrate preference of uracil-DNA glycosylase. J Biol Chem 273: 45-50
182. Partidos CD, Hoebeke J, Moreau E, et al. (2005) the binding affinity of double-stranDed RNA motifs to HIV-1 Tat protein affects transactivation and the neutralizing capacity of anti-Tat antibodies elicited after intranasal immunization. Eur J Immunol 35:1521-9
183. Pashov A, MacLeod S, Saha R, et al. (2005). Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12. Glycobiology 15:994-1001
184. Peters H, Kusov YY, Meyer S, et al. (2005). Hepatitis A virus proteinase 3C binding to viral RNA: correlation with substrate binding and enzyme dimerization. Biochem J 385:363-70
185. Pettigrew DM, Williams DT, Kerrigan D, et al. (2006). Structural and functional insights into the interaction of echoviruses and Decayaccelerating factor. J Biol Chem 281:5169-77
186. Philpott N, Bakken T, Pennell C, et al. (2011) the Kaposis sarcomaassociated herpes virus G protein-coupled receptor contains an immunoreceptor tyrosine-based inhibitory motif that activates Shp2,. J Virol 85:1140-4
187. Quyen DV, Ha SC, Lowenhaupt K, et al. (2007). Characterization of DNA-binding activity of Z alpha domains from poxviruses and the importance of the beta-wing regions in converting B-DNA to Z-DNA. Nucleic Acids Res 35:7714-20
188. Ramboarina S, Druillennec S, Morellet N, et al. (2004). Target specificity of human immunoDeficiency virus type 1 NCp7 requires an intact conformation of its CCHC N-terminal zinc finger. J Virol 78: 6682-7
189. Ramcharan J, Colleluori DM, Merkel G, et al. (2006). MoDe of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody. Retrovirology 3:34
190. RoohVand F, Maillard P, Lavergne JP, et al. (2009). Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein. J Biol Chem 284:13778-91
191. Rusnati M, Bugatti A, Mitola S, et al. (2009). Exploiting Surface Plasmon Resonance (SPR) technology for the iDentification of fibroblast growth factor-2 (FGF2) antagonists endowed with antiangiogenic activity. Sensors (Basel) 9:6471-503
192. Rusnati M, Presta M. (2002). HIV-1 Tat protein: a target for the Development of anti-AIDS therapies. Drug Fut 27:481-493
193. Rusnati M, Urbinati C, Caputo A, et al. (2001). Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem 276: 22420-5
194. Ryzhova E, Whitbeck JC, Canziani G, et al. (2002). Rapid progression to simian AIDS can be accompanied by selection of CD4-inDepenDent gp120 variants with impaired ability to bind CD4. J Virol 76:7903-9
195. Sabbah EN, Delaunay T, Varin A, et al. (2006). Development and characterization of ten monoclonal anti-Vpr antibodies. AIDS Res Hum Retroviruses 22:630-9
196. Sabile A, Perlemuter G, Bono F, et al. (1999). Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30:1064-76
197. Saitoh T, Kuramochi K, Imai T, et al. (2008). Podophyllotoxin directly binds a hinge domain in E2 of HPV and inhibits an E2/E7 interaction in vitro. Bioorg Med Chem 16:5815-25
198. Santiago C, Bjorling E, Stehle T, Casasnovas JM. (2002). Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. J Biol Chem 277: 32294-301
199. Sarrias MR, Franchini S, Canziani G, et al. (2001). Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J Immunol 167:1490-9
200. Seco J, Luque FJ, Barril X. (2009). Binding site Detection and druggability inDex from first principles. J Med Chem 52:2363-71
201. Seet BT, Barrett J, Robichaud J, et al. (2001a). Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1. J Biol Chem 276:30504-13
202. Seet BT, Singh R, Paavola C, et al. (2001b). Molecular Determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc Natl Acad Sci U S A 98:9008-13
203. Seiradake E, Lortat-Jacob H, Billet O, et al. (2006). Structural and mutational analysis of human Ad37 and canine aDenovirus 2 fiber heads in complex with the D1 domain of coxsackie and aDenovirus receptor. J Biol Chem 281:33704-16
204. Seo NS, Zeng CQ, Hyser JM, et al. (2008). Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A 105:8811-18
205. Shelton H, Harris M. (2008). Hepatitis C virus NS5A protein binds the SH3 domain of the Fyn tyrosine kinase with high affinity: mutagenic analysis of residues within the SH3 domain that contribute to the interaction. Virol J 5:24
206. Shi J, Gonzales RA, Bhattacharyya MK. (1996). IDentification and characterization of an S-ADenosyl-L-methionine: Delta 24-sterol-C-methyltransferase cDNA from soybean. J Biol Chem 271:9384-9
207. Shih PC, Yang MS, Lin SC, et al. (2009). A turn-like structure KKPE segment mediates the specific binding of viral protein A27 to heparin and heparan sulfate on cell surfaces. J Biol Chem 284: 36535-46
208. Smith EA, Kyo M, Kumasawa H, et al. (2002). Chemically induced hairpin formation in DNA monolayers. J Am Chem Soc 124: 6810-11
209. Smith SA, Kotwal GJ. (2001). Virokines: novel immunomodulatory agents. Expert Opin Biol Ther 1:343-57
210. Smith SA, Sreenivasan R, Krishnasamy G, et al. (2003). Mapping of regions within the vaccinia virus complement control protein involved in dose-DepenDent binding to key complement components and heparin using surface plasmon resonance. Biochim Biophys Acta 1650:30-9
211. Solbak SM, Reksten TR, Hahn F, et al. (2012). HIV-1 p6-A structured to flexible multifunctional membrane-interacting protein. Biochim Biophys Acta 1828:816-23
212. Solbak SM, Reksten TR, Wray V, et al. (2010) the intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding. BMC Struct Biol 10:31
213. Solbak SM, Wray V, Horvli O, et al. (2011) the hostpathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains. BMC Struct Biol 11:49
214. Sorathiya A, Bracciali A, Lio P. (2010). Formal reasoning on qualitative moDels of coinfection of HIV and Tuberculosis and HAART therapy. BMC Bioinformatics 11:S67
215. Spencer KA, Hiscox JA. (2006). Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino-terminal region. FEBS Lett 580:5993-8
216. Spiller OB, Blackbourn DJ, Mark L, et al. (2003). Functional activity of the complement regulator encoDed by Kaposis sarcoma-Associated herpesvirus. J Biol Chem 278:9283-9
217. Sprague ER, Reinhard H, Cheung EJ, et al. (2008) the human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol 82:3490-9
218. Stamminger T. (2008). Interactions of human cytomegalovirus proteins with the nuclear transport machinery. Curr Top Microbiol Immunol 325:167-85
219. Stephen AG, Datta SA, Worthy KM, et al. (2007). Measuring the binding stoichiometry of HIV-1 Gag to very-low-Density oligonucleotiDe surfaces using surface plasmon resonance spectroscopy. J Biomol Tech 18:259-66
220. Stricher F, Huang CC, Descours A, et al. (2008). Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. J Mol Biol 382:510-24
221. Suenaga E, Mizuno H, Penmetcha KK. (2012). Monitoring influenza hemagglutinin and glycan interactions using surface plasmon resonance. Biosens Bioelectron 32:195-201
222. Sun ZY, Oh KJ, Kim M, et al. (2008). HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28:52-63
223. Symons JA, Tscharke DC, Price N, Smith GL. (2002). A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol 83:1953-64
224. Takahashi H, Sawa H, Hasegawa H, et al. (2004). Topoisomerase I dissociates human immunoDeficiency virus type 1 reverse transcriptase from genomic RNAs. Biochem Biophys Res Commun 313: 1073-8
225. Takeda E, Murakami T, Matsuda G, et al. (2011). Nuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 Vpr. PLoS One 6:e27815
226. Takemoto DK, Skehel JJ, Wiley DC. (1996). A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor. Virology 217:452-8
227. Tanaka Y, Shimoike T, Ishii K, et al. (2000). Selective binding of hepatitis C virus core protein to synthetic oligonucleotiDes corresponding to the 5 untranslated region of the viral genome. Virology 270:229-36
228. Tarus B, Bakowiez O, Chenavas S, et al. (2012). Oligomerization paths of the nucleoprotein of influenza A virus. Biochimie 94:776-85
229. Taube S, Jiang M, Wobus CE. (2010). Glycosphingolipids as receptors for non-enveloped viruses. Viruses 2:1011-49
230. Taylor MP, Koyuncu OO, Enquist LW. (2011). Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol 9:427-39
231. ter Meulen J, Van Den Brink EN, Poon LL, et al 2006. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3. e237
232. Terao-Muto Y, Yoneda M, Seki T, et al. (2008). Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines. Antiviral Res 80:370-6
233. Timmins J, Schoehn G, Ricard-Blum S, et al. (2003). Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol 326:493-502
234. Trinh HV, Lesage G, Chennamparampil V, et al. (2012). Avidity binding of human aDenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J Virol 86:1623-37
235. Tripet B, Kao DJ, Jeffers SA, et al. (2006). Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus. J Struct Biol 155:176-94
236. Tsirulnikov K, Abuladze N, Vahi R, et al. (2012). Aminoacylase 3 binds to and cleaves the N-terminus of the hepatitis C virus core protein. FEBS Lett 586:3799-804
237. Twarock R. (2006). Mathematical virology: a novel approach to the structure and assembly of viruses. Philos Transact A Math Phys Eng Sci 364:3357-73
238. Urbinati C, Bugatti A, Giacca M, et al. (2005). alpha(v)beta3-integrinDepenDent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells. J Cell Sci 118:3949-58
239. Urbinati C, Bugatti A, Oreste P, et al. (2004). Chemically sulfated Escherichia coli K5 polysacchariDe Derivatives as extracellular HIV-1 Tat protein antagonists. FEBS Lett 568:171-7
240. Urbinati C, ChioDelli P, Rusnati M. (2008). Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-Associated inflammation and angiogenesis. Molecules 13:2758-85
241. Vaisocherova H, Mrkvova K, Piliarik M, et al. (2007). Surface plasmon resonance biosensor for direct Detection of antibody against Epstein-Barr virus. Biosens Bioelectron 22:1020-6
242. Van Ryk DI, Venkatesan S. (1999). Real-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis. J Biol Chem 274: 17452-63
243. VanCott TC, Bethke FR, Kalyanaraman V, et al. (1994). Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules. J Acquir Immune Defic Syndr 7:1103-15
244. Veiga AS, PattenDen LK, Fletcher JM, et al. (2009). Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane moDel systems. Chembiochem 10:1032-44
245. Viejo-Borbolla A, Martinez-Martin N, Nel HJ, et al. (2012). Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses. PLoS Pathog 8: e1002497
246. Viswanathan K, Fruh K. (2007). Viral proteomics: global evaluation of viruses and their interaction with the host. Expert Rev Proteomics 4: 815-29
247. Vitagliano L, Fiume G, Scognamiglio PL, et al. (2011). Structural and functional insights into IkappaB-Alpha/HIV-1 Tat interaction. Biochimie 93:1592-600
248. Waddington SN, McVey JH, Bhella D, et al. (2008). ADenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397-409
249. Wang H, Li ZY, Liu Y, et al. (2010a). Desmoglein 2 is a receptor for aDenovirus serotypes 3, 7, 11 and 14. Nat Med 17:96-104
250. Wang H, Liaw YC, Stone D, et al. (2007). IDentification of CD46 binding sites within the aDenovirus serotype 35 fiber knob. J Virol 81: 12785-92
251. Wang Q, Li C, Zhang Q, et al. (2010b). Interactions of SARS coronavirus nucleocapsid protein with the host cell proteasome subunit p42. Virol J 7:99
252. Wang W, Cole AM, Hong T, et al. (2003). Retrocyclin, an antiretroviral theta-Defensin, is a lectin. J Immunol 170:4708-16
253. West ML, Ramsdale TE. (1996). Binding kinetics and bioassay of RRE mRNA fragments to a peptiDe containing the recognition domain of HIV-1 Rev. Biomed Pept Proteins Nucleic Acids 2:85-8
254. Wilkinson TA, Januszyk K, Phillips ML, et al. (2009). IDentifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase. J Biol Chem 284:7931-9
255. Williams RK, Straus SE. (1997). Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans. J Virol 71:1375-80
256. Willis SH, Rux AH, Peng C, et al. (1998). Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance. J Virol 72:5937-47
257. WunDerlich K, Juozapaitis M, Ranadheera C, et al. (2011). IDentification of high-Affinity PB1-Derived peptiDes with enhanced affinity to the PA protein of influenza A virus polymerase. Antimicrob Agents Chemother 55:696-702
258. Xiang Y, Moss B. (2003). Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furincleaved form with only the IL-18 binding domain. J Virol 77:2623-30
259. Xiao Y, Wu W, Dierich MP, Chen Y. (2000). HIV-1 gp41 by N-domain binds the potential receptor protein P45. Int Arch Allergy Immunol 121:253-7
260. Xing L, Tjarnlund K, Lindqvist B, et al. (2000). Distinct cellular receptor interactions in poliovirus and rhinoviruses. EMBO J 19:1207-16
261. Yadav VN, Pyaram K, Mullick J, Sahu A. (2008). IDentification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. J Virol 82:3283-94
262. Yang Y, Wang Q, Guo D. (2008). A novel strategy for analyzing RNAprotein interactions by surface plasmon resonance biosensor. Mol Biotechnol 40:87-93
263. Yasin B, Wang W, Pang M, et al. (2004) theta Defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 78:5147-56
264. Yi J, Asante-Appiah E, Skalka AM. (1999). Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase. Biochemistry 38:8458-68
265. Yoon SI, Jones BC, Logsdon NJ, et al. (2012). Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties. J Biol Chem 287:26586-95
266. Yu JS, Liao HX, Gerdon AE, et al. (2006). Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor. J Virol Methods 137:219-28
267. Zanier K, Charbonnier S, Baltzinger M, et al. (2005). Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J Mol Biol 349:401-12
268. Zanier K, Ruhlmann C, Melin F, et al. (2009). E6 proteins from diverse papillomaviruses self-Associate both in vitro and in vivo. J Mol Biol 396:90-104
269. Zhang F, Fath M, Marks R, Linhardt RJ. (2002). A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies. Anal Biochem 304:271-3
270. Zhang Q, Hunke C, Yau YH, et al. (2012) the stem region of premembrane protein plays an important role in the virus surface protein rearrangement during Dengue maturation. J Biol Chem 287: 40525-34
271. Zhang X, Oglesbee M. (2003). Use of surface plasmon resonance for the measurement of low affinity binding interactions between HSP72 and measles virus nucleocapsid protein. Biol Proced Online 5:170-81
272. Zhao D, Wang X, Lou G, et al. (2010). APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems. Virus Res 151:213-19
273. Zhao Q, Ma L, Jiang S, et al. (2005). IDentification of N-phenyl-N0-(2, 2, 6, 6-tetramethyl-piperidin-4-yl)-oxalamiDes as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology 339:213-25
274. Zhou B, Liu J, Wang Q, et al. (2008) the nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha. J Virol 82:6962-71
275. Zhu J, Mactutus CF, Wallace DR, Booze RM. (2009). HIV-1 Tat proteininduced rapid and reversible Decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35 428) binding in rat striatal synaptosomes. J Pharmacol Exp Ther 329:1071-83
276. Zlotnick A, Mukhopadhyay S. (2011). Virus assembly, allostery and antivirals. Trends Microbiol 19:14-23